Alternative mechanisms of action of cationic antimicrobial peptides on bacteria

References

• Hancock REW, Chapple DS. Peptide antibiotics. Antimicrob. Agents Chemother.43(6), 1317–1323 (1999).
   PubMed Web of Science ®Google Scholar
• Jenssen H, Hamill P, Hancock REW. Peptide antimicrobial agents. Clin. Microbiol. Rev.19(3), 491–511 (2006).
   PubMed Web of Science ®Google Scholar
• Brown KL, Hancock REW. Cationic host defense (antimicrobial) peptides. Curr. Opin. Immunol.18(1), 24–30 (2006).
   PubMed Web of Science ®Google Scholar
• Powers JP, Hancock REW. The relationship between peptide structure and antibacterial activity. Peptides24(11), 1681–1691 (2003).
   PubMed Web of Science ®Google Scholar
• Hancock REW, Sahl HG. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol.24(12), 1551–1557 (2006).
   PubMed Web of Science ®Google Scholar
• Peschel A, Sahl HG. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol.4(7), 529–536 (2006).
   PubMed Web of Science ®Google Scholar
• Kraus D, Peschel A. Molecular mechanisms of bacterial resistance to antimicrobial peptides. Curr. Top. Microbiol. Immunol.306, 231–250 (2006).
   PubMed Web of Science ®Google Scholar
• Hancock REW, Patrzykat A. Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics. Curr. Drug Targets Infect. Disord.2(1), 79–83 (2002).
   PubMedGoogle Scholar
• Marshall SH, Arenas G. Antimicrobial peptides: a natural alternative to chemical antibiotics and a potential for applied biotechnology. Electron. J. Biotechnol.6(2), 265–272 (2003).
   Google Scholar
• Gifford JL, Hunter HN, Vogel HJ. Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell. Mol. Life Sci.62(22), 2588–2598 (2005).
   PubMed Web of Science ®Google Scholar
• Chen X, Niyonsaba F, Ushio H et al. Synergistic effect of antibacterial agents human β-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. J. Dermatol. Sci.40(2), 123–132 (2005).
   PubMed Web of Science ®Google Scholar
• Hilpert K, Volkmer-Engert R, Walter T, Hancock REW. High-throughput generation of small antibacterial peptides with improved activity. Nat. Biotechnol.23(8), 1008–1012 (2005).
   PubMed Web of Science ®Google Scholar
• Blondelle SE, Lohner K. Combinatorial libraries: a tool to design antimicrobial and antifungal peptide analogues having lytic specificities for structure–activity relationship studies. Biopolymers55(1), 74–87 (2000).
   PubMed Web of Science ®Google Scholar
• Straus SK, Hancock REW. Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides. Biochim. Biophys. Acta1758(9), 1215–1223 (2006).
   PubMed Web of Science ®Google Scholar
• Hancock REW. Peptide antibiotics. Lancet349(9049), 418–422 (1997).
   PubMed Web of Science ®Google Scholar
• Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol.3(3), 238–250 (2005).
   PubMed Web of Science ®Google Scholar
• Wu M, Maier E, Benz R, Hancock REW. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry38(22), 7235–7242 (1999).
   PubMed Web of Science ®Google Scholar
• Yang L, Harroun TA, Heller WT, Weiss TM, Huang HW. Neutron off-plane scattering of aligned membranes. I. Method of measurement. Biophys. J.75(2), 641–645 (1998).
   PubMed Web of Science ®Google Scholar
• Matsuzaki K, Murase O, Fujii N, Miyajima K. An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochemistry35(35), 11361–11368 (1996).
   PubMed Web of Science ®Google Scholar
• Gazit E, Boman A, Boman HG, Shai Y. Interaction of the mammalian antibacterial peptide cecropin P1 with phospholipid vesicles. Biochemistry34(36), 11479–11488 (1995).
   PubMed Web of Science ®Google Scholar
• Bechinger B, Lohner K. Detergent-like actions of linear amphipathic cationic antimicrobial peptides. Biochim. Biophys. Acta1758(9), 1529–1539 (2006).
   PubMed Web of Science ®Google Scholar
• Shai Y. Molecular recognition between membrane-spanning polypeptides. Trends Biochem. Sci.20(11), 460–464 (1995).
   PubMed Web of Science ®Google Scholar
• Patrzykat A, Friedrich CL, Zhang L, Mendoza V, Hancock REW. Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob. Agents Chemother.46(3), 605–614 (2002).
   PubMed Web of Science ®Google Scholar
• Hong RW, Shchepetov M, Weiser JN, Axelsen PH. Transcriptional profile of the Escherichia coli response to the antimicrobial insect peptide cecropin A. Antimicrob. Agents Chemother.47(1), 1–6 (2003).
   PubMed Web of Science ®Google Scholar
• Haukland HH, Ulvatne H, Sandvik K, Vorland LH. The antimicrobial peptides lactoferricin B and magainin 2 cross over the bacterial cytoplasmic membrane and reside in the cytoplasm. FEBS Lett.508(3), 389–393 (2001).
   PubMed Web of Science ®Google Scholar
• Park CB, Kim MS, Kim SC. A novel antimicrobial peptide from Bufo bufo gargarizans. Biochem. Biophys. Res. Commun.218(1), 408–413 (1996).
   PubMed Web of Science ®Google Scholar
• Park CB, Kim HS, Kim SC. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem. Biophys. Res. Commun.244(1), 253–257 (1998).
   PubMed Web of Science ®Google Scholar
• Park CB, Yi KS, Matsuzaki K, Kim MS, Kim SC. Structure–activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. Proc. Natl Acad. Sci. USA97(15), 8245–8250 (2000).
   PubMed Web of Science ®Google Scholar
• Hirsch JG. Bactericidal action of histone. J. Exp. Med.108(6), 925–944 (1958).
   PubMed Web of Science ®Google Scholar
• Birkemo GA, Luders T, Andersen O, Nes IF, Nissen-Meyer J. Hipposin, a histone-derived antimicrobial peptide in Atlantic halibut (Hippoglossus hippoglossus L.). Biochim. Biophys. Acta1646(1–2), 207–215 (2003).
   PubMed Web of Science ®Google Scholar
• Park IY, Park CB, Kim MS, Kim SC. Parasin I, an antimicrobial peptide derived from histone H2A in the catfish, Parasilurus asotus. FEBS Lett.437(3), 258–262 (1998).
   PubMed Web of Science ®Google Scholar
• Hsu C-H, Chen C, Jou M-L et al. Structural and DNA-binding studies on the bovine antimicrobial peptide, indolicidin: evidence for multiple conformations involved in binding to membranes and DNA. Nucl. Acids Res.33(13), 4053–4064 (2005).
   PubMed Web of Science ®Google Scholar
• Tomasinsig L, Zanetti M. The cathelicidins – structure, function and evolution. Curr. Protein Pept. Sci.6(1), 23–34 (2005).
   PubMed Web of Science ®Google Scholar
• Falla TJ, Karunaratne DN, Hancock RE. Mode of action of the antimicrobial peptide indolicidin. J. Biol. Chem.271(32), 19298–19303 (1996).
   PubMed Web of Science ®Google Scholar
• Subbalakshmi C, Sitaram N. Mechanism of antimicrobial action of indolicidin. FEMS Microbiol. Lett.160(1), 91–96 (1998).
   PubMed Web of Science ®Google Scholar
• Marchand C, Krajewski K, Lee HF et al. Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites. Nucl. Acids Res.34(18), 5157–5165 (2006).
   PubMed Web of Science ®Google Scholar
• Friedrich CL, Rozek A, Patrzykat A, Hancock REW. Structure and mechanism of action of an indolicidin peptide derivative with improved activity against Gram-positive bacteria. J. Biol. Chem.276(26), 24015–24022 (2001).
   PubMed Web of Science ®Google Scholar
• Agerberth B, Lee JY, Bergman T et al. Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. Eur. J. Biochem.202(3), 849–854 (1991).
   PubMedGoogle Scholar
• Shi J, Ross CR, Chengappa MM, Blecha F. Identification of a proline-arginine-rich antibacterial peptide from neutrophils that is analogous to PR-39, an antibacterial peptide from the small intestine. J. Leukoc. Biol.56(6), 807–811 (1994).
   PubMed Web of Science ®Google Scholar
• Boman HG, Agerberth B, Boman A. Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect. Immun.61(7), 2978–2984 (1993).
   PubMed Web of Science ®Google Scholar
• Cole AM, Weis P, Diamond G. Isolation and characterization of pleurocidin, an antimicrobial peptide in the skin secretions of winter flounder. J. Biol. Chem.272(18), 12008–12013 (1997).
   PubMed Web of Science ®Google Scholar
• Otvos L Jr, O I, Rogers ME et al. Interaction between heat shock proteins and antimicrobial peptides. Biochemistry39(46), 14150–14159 (2000).
   PubMed Web of Science ®Google Scholar
• Kragol G, Lovas S, Varadi G et al. The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding. Biochemistry40(10), 3016–3026 (2001).
   PubMed Web of Science ®Google Scholar
• Salomon RA, Farias RN. Microcin 25, a novel antimicrobial peptide produced by Escherichia coli. J. Bacteriol.174(22), 7428–7435 (1992).
   Google Scholar
• Sahl HG, Pag U, Bonness S et al. Mammalian defensins: structures and mechanism of antibiotic activity. J. Leukoc. Biol.77(4), 466–475 (2005).
   PubMed Web of Science ®Google Scholar
• Brotz H, Josten M, Wiedemann I et al. Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol. Microbiol.30(2), 317–327 (1998).
   PubMed Web of Science ®Google Scholar
• Breukink E, Wiedemann I, van Kraaij C et al. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science286(5448), 2361–2364 (1999).
   PubMed Web of Science ®Google Scholar
• Breukink E, de Kruijff B. Lipid II as a target for antibiotics. Nat. Rev. Drug Discov.5(4), 321–332 (2006).
   PubMed Web of Science ®Google Scholar
• Bierbaum G, Sahl HG. Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase. J. Bacteriol.169(12), 5452–5458 (1987).
   PubMed Web of Science ®Google Scholar
• Hasper HE, Kramer NE, Smith JL et al. An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II. Science313(5793), 1636–1637 (2006).
   PubMed Web of Science ®Google Scholar
• Morency H, Mota-Meira M, LaPointe G, Lacroix C, Lavoie MC. Comparison of the activity spectra against pathogens of bacterial strains producing a mutacin or a lantibiotic. Can. J. Microbiol.47(4), 322–331 (2001).
   PubMed Web of Science ®Google Scholar
• Amsterdam D. Susceptibility testing of antimicrobials in liquid media. In: Antibiotics in Laboratory Medicine. Lorian V (Ed.). Williams and Wilkins, MD, USA 52–111 (1996).
   Google Scholar
• Yan H, Hancock REW. Synergistic interactions between mammalian antimicrobial defense peptides. Antimicrob. Agents Chemother.45(5), 1558–1560 (2001).
   PubMed Web of Science ®Google Scholar
• Milona P, Townes CL, Bevan RM, Hall J. The chicken host peptides, gallinacins 4, 7, and 9 have antimicrobial activity against Salmonella serovars. Biochem. Biophys. Res. Commun.356(1), 169–174 (2007).
   PubMed Web of Science ®Google Scholar
• Scott MG, Yan H, Hancock REW. Biological properties of structurally related α-helical cationic antimicrobial peptides. Infect. Immun.67(4), 2005–2009 (1999).
   PubMed Web of Science ®Google Scholar
• Cirioni O, Giacometti A, Kamysz W et al. In vitro activities of tachyplesin III against Pseudomonas aeruginosa. Peptides28(4), 747–751 (2007).
   PubMed Web of Science ®Google Scholar
• Otvos L Jr, de Olivier Inacio V, Wade JD, Cudic P. Prior antibacterial peptide-mediated inhibition of protein folding in bacteria mutes resistance enzymes. Antimicrob. Agents Chemother.50(9), 3146–3149 (2006).
   PubMed Web of Science ®Google Scholar
• Mookherjee N, Brown KL, Bowdish DM et al. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J. Immunol.176(4), 2455–2464 (2006).
   PubMed Web of Science ®Google Scholar
• Dennis EA, Rhee SG, Billah MM, Hannun YA. Role of phospholipase in generating lipid second messengers in signal transduction. FASEB J.5(7), 2068–2077 (1991).
   PubMed Web of Science ®Google Scholar
• Qu XD, Lehrer RI. Secretory phospholipase A2 is the principal bactericide for staphylococci and other Gram-positive bacteria in human tears. Infect. Immun.66(6), 2791–2797 (1998).
   PubMed Web of Science ®Google Scholar
• Zhao H, Kinnunen PK. Modulation of the activity of secretory phospholipase A2 by antimicrobial peptides. Antimicrob. Agents Chemother.47(3), 965–971 (2003).
   PubMed Web of Science ®Google Scholar
• Jia X, Patrzykat A, Devlin RH et al. Antimicrobial peptides protect coho salmon from Vibrio anguillarum infections. Appl. Environ. Microbiol.66(5), 1928–1932 (2000).
   PubMed Web of Science ®Google Scholar
• Blondelle SE, Perez-Paya E, Houghten RA. Synthetic combinatorial libraries: novel discovery strategy for identification of antimicrobial agents. Antimicrob. Agents Chemother.40(5), 1067–1071 (1996).
   PubMed Web of Science ®Google Scholar
• Loose C, Jensen K, Rigoutsos I, Stephanopoulos G. A linguistic model for the rational design of antimicrobial peptides. Nature443(7113), 867–869 (2006).
   PubMed Web of Science ®Google Scholar
• Zasloff M. Antimicrobial peptides of multicellular organisms. Nature415(6870), 389–395 (2002).
   PubMed Web of Science ®Google Scholar
• Bechinger B. The structure, dynamics and orientation of antimicrobial peptides in membranes by multidimensional solid-state NMR spectroscopy. Biochim. Biophys. Acta1462(1–2), 157–183 (1999).
   PubMed Web of Science ®Google Scholar